Samantha Larsen, - Speech-Language Pathologist in Windham, NH

Samantha Larsen, is a Speech-language Pathologist based in Windham, New Hampshire. Samantha Larsen is licensed to practice in New Hampshire (license number 1424) and her current practice location is 19 Haverhill Rd, Windham, New Hampshire. She can be reached at her office (for appointments etc.) via phone at (603) 845-1552.

NPI number for Samantha Larsen is 1346842804 and her current mailing address is 19 Haverhill Rd, Windham, New Hampshire. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1346842804.

Contact Information

Samantha Larsen,
19 Haverhill Rd,
Windham, NH 03087-1517
(603) 845-1552
Not Available



Healthcare Provider's Profile

Full NameSamantha Larsen
GenderFemale
SpecialitySpeech-language Pathologist
Location19 Haverhill Rd, Windham, New Hampshire
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1346842804
  • Provider Enumeration Date: 11/10/2020
  • Last Update Date: 11/10/2020

Medical Identifiers

Medical identifiers for Samantha Larsen such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1346842804NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 1424 (New Hampshire)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Samantha Larsen is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Samantha Larsen,
19 Haverhill Rd,
Windham, NH 03087-1517

Ph: () -
Samantha Larsen,
19 Haverhill Rd,
Windham, NH 03087-1517

Ph: (603) 845-1552

News Archive

PerkinElmer announces release of 200th umbilical cord blood stem cell unit

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that its family cord blood banking business, ViaCord, has released its 200th umbilical cord blood stem cell unit for treatment purposes. The 200th unit will be used in a clinical trial intended to treat cerebral palsy with a re-infusion of a child's own umbilical cord stem cells.

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Trevena, Inc., a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor biased ligands, and Forest Laboratories Holding Limited, a subsidiary of Forest Laboratories Inc., an international pharmaceutical company, announced today that they have entered into a collaborative licensing option agreement for the development of TRV027, an AT1R biased-ligand that recently completed Phase 2a clinical trials.

Roche, CPRIT partner to advance cancer research projects in Texas

The Cancer Prevention and Research Institute of Texas (CPRIT) today announced a strategic partnership agreement with the Swiss-based healthcare company Roche to accelerate the development of promising oncology-related cancer research projects in Texas.

Leading medical groups collaborate to ensure consistent, responsible uptake of TAVR

With the U.S. Food and Drug Administration's recent approval of transcatheter aortic valve replacement (TAVR) for patients with aortic valvular stenosis, the American College of Cardiology Foundation (ACCF), along with the American Association for Thoracic Surgery (AATS), the Society for Cardiovascular Angiography and Interventions (SCAI) and the Society of Thoracic Surgeons (STS), today released an expert consensus document to provide important guidance on its use.

Read more News

› Verified 6 days ago


Speech-Language Pathologist in Windham, NH

Alana Chown,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 19 Haverhill Rd, Windham, NH 03087
Phone: 603-845-1552    
Kelly Cline,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 21 Searles Rd, Windham, NH 03087
Phone: 603-890-1290    
Diane Bagarella,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 3 Industrial Drive, Unit 1, Windham, NH 03087
Phone: 603-870-0078    Fax: 603-870-8134
Kara Clark-hartshorne,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 19 Haverhill Rd, Windham, NH 03087
Phone: 603-845-1552    
Jamie Harrington,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 3 Industrial Dr Unit 1, Windham, NH 03087
Phone: 603-870-0078    
Ms. Annie Divello,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 21 Searles Rd, Windham, NH 03087
Phone: 603-890-1290    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.